The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
Julia Miriam Weiss(Sorbonne Université), Nadège Bercovici(Centre National de la Recherche Scientifique), Isabelle Galy–Fauroux(Délégation Paris 5), Fabienne Régnier(Délégation Paris 5), Gilles Renault(Centre National de la Recherche Scientifique), Lene Vimeux(Délégation Paris 5), Marion V. Guérin(Inserm), Alain Trautmann(Centre National de la Recherche Scientifique), Maxime Thoreau(Délégation Paris 5), Elisa Peranzoni(Centre National de la Recherche Scientifique), Vincent Feuillet(Délégation Paris 5)
Cited by 110
Related Papers
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
|Proceedings of the National Academy of Sciences|2018|948
Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth
|Nature Cell Biology|2015|183
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
|Nature Cancer|2023|137
The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
|Frontiers in Immunology|2019|129